Xenon Pharmaceuticals IPO Research Information

Xenon Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Xenon Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Xenon Pharmaceuticals	XENE - NASDAQ	$10.00-$12.00	$9.00	$10.02	4 million	11/5/2014
Underwriter(s): Jefferies, Wells Fargo Securities
Co-Manager(s): Canaccord Genuity
Industry: Health Care
Filing(s): Filed 2014-09-10 Terms Added 2014-10-06

Xenon Pharmaceuticals Quote & Chart - Click for current quote - XENE

About Xenon Pharmaceuticals (adapted from Xenon Pharmaceuticals prospectus):
They are a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications that they intend to commercialize on their own, and for larger market indications that they intend to partner with global pharmaceutical companies.

This description is adapted from Xenon Pharmaceuticals prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Xenon Pharmaceuticals "XENE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.